| Year |
Citation |
Score |
| 2018 |
Buck D, Andlauer TF, Igl W, Wicklein EM, Mühlau M, Weber F, Köchert K, Pohl C, Arnason B, Comi G, Cook S, Filippi M, Hartung HP, Jeffery D, Kappos L, et al. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763089. PMID 29521573 DOI: 10.1177/1352458518763089 |
0.305 |
|
| 2015 |
Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, et al. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. Jama Neurology. 1-8. PMID 26458124 DOI: 10.1001/Jamaneurol.2015.2742 |
0.334 |
|
| 2015 |
Hartung HP, Kappos L, Goodin DS, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Petkau J, White R, Bogumil T, Beckmann K, Stemper B, Suarez G, et al. Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. Journal of Neurology. PMID 26239222 DOI: 10.1007/S00415-015-7862-9 |
0.351 |
|
| 2012 |
Hartung HP, Kieseier B, Goodin DS, Arnason BG, Comi G, Cook S, Filippi M, Jeffery DR, Kappos L, Bogumil T, Stemper B, Sandbrink R, Nakada Y, Nakajima H, Schwenke S, et al. Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies. Journal of Neuroinflammation. 9: 129. PMID 22703536 DOI: 10.1186/1742-2094-9-129 |
0.311 |
|
| 2012 |
Goodin DS, Hartung HP, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Kappos L, Bogumil T, Knappertz V, Sandbrink R, Beckmann K, White R, Petkau J, et al. Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 181-95. PMID 21952094 DOI: 10.1177/1352458511418629 |
0.31 |
|
| 2012 |
Hartung H, Kappos L, Goodin D, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Petkau J, Bogumil T, Knappertz V, Beckmann K, Stemper B, Pohl C, et al. Predictors of Disease Activity in 857 MS Patients Treated with IFNB-1b (PD5.009) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd5.009 |
0.301 |
|
| 2012 |
Jensen M, Reder A, Niewold T, Franek B, Arnason B. Characterization of Blood-Derived Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Multiple Sclerosis (MS) Patients, Healthy Controls, and Systemic Lupus Erythematosus (SLE) Patients (P02.101) Neurology. 78: P02.101-P02.101. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.101 |
0.358 |
|
| 2011 |
Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, ... ... Arnason BG, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 70: 897-912. PMID 22190364 DOI: 10.1002/Ana.22609 |
0.465 |
|
| 2011 |
Acaster S, Swinburn P, Wang C, Stemper B, Beckmann K, Knappertz V, Pohl C, Sandbrink R, Gondek K, Edan G, Kappos L, Freedman M, Hartung HP, Arnason B, Comi G, et al. Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1504-13. PMID 21757536 DOI: 10.1177/1352458511414039 |
0.321 |
|
| 2011 |
Othman A, Frim DM, Polak P, Vujicic S, Arnason BG, Boullerne AI. Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia. 59: 914-26. PMID 21446039 DOI: 10.1002/Glia.21163 |
0.697 |
|
| 2010 |
Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 30-8. PMID 20007427 DOI: 10.1177/1352458509352794 |
0.369 |
|
| 2009 |
O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung HP, Jeffery D, Kappos L, Boateng F, Filippov V, Groth M, Knappertz V, Kraus C, Sandbrink R, ... ... Arnason B, et al. 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. The Lancet. Neurology. 8: 889-97. PMID 19729344 DOI: 10.1016/S1474-4422(09)70226-1 |
0.303 |
|
| 2008 |
Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 809-14. PMID 18573828 DOI: 10.1177/1352458508088941 |
0.302 |
|
| 2007 |
Jensen MA, Arnason BG, White DM. A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors. European Journal of Immunology. 37: 1139-48. PMID 17393382 DOI: 10.1002/Eji.200636321 |
0.308 |
|
| 2007 |
Wolinsky JS, Narayana PA, O'Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani D, Kastrukoff L, Duquette P, Freedman M, Debouverie M, Lubetski C, ... ... Arnason B, et al. Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial Annals of Neurology. 61: 14-24. PMID 17262850 DOI: 10.1002/Ana.21079 |
0.517 |
|
| 2005 |
Arnason BG. Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis. Journal of Neurology. 252: iii28-iii33. PMID 16170497 DOI: 10.1007/S00415-005-2014-2 |
0.374 |
|
| 2004 |
Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Arnason B, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurorx. 1: 506-514. DOI: 10.1602/Neurorx.1.4.506 |
0.359 |
|
| 2004 |
Wolinsky JS, Kastrukoff L, Duquette P, Freedman M, O'Connor P, Debouverie M, Lubetski C, Edan G, Roullet E, Confavreux C, Thompson A, Blumhardt L, Hawkins S, Scott T, Wynn D, ... ... Arnason B, et al. The PROMiSe trial: baseline data review and progress report. Multiple Sclerosis Journal. 10. DOI: 10.1191/1352458504Ms1034Oa |
0.303 |
|
| 2003 |
Paty D, Arnason B, Li D, Traboulsee A. Interferons in relapsing remitting multiple sclerosis. Lancet (London, England). 361: 1822; author reply 1. PMID 12781559 DOI: 10.1016/S0140-6736(03)13418-6 |
0.355 |
|
| 2002 |
Boullerne AI, Rodriguez JJ, Touil T, Brochet B, Schmidt S, Abrous ND, Le Moal M, Pua JR, Jensen MA, Mayo W, Arnason BG, Petry KG. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 123-32. PMID 11756495 DOI: 10.1523/Jneurosci.22-01-00123.2002 |
0.754 |
|
| 2001 |
Qu ZX, Pliskin N, Jensen MW, White D, Arnason BG. Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Archives of Neurology. 58: 87-90. PMID 11176940 DOI: 10.1001/Archneur.58.1.87 |
0.362 |
|
| 1999 |
Arnason BG. Immunologic therapy of multiple sclerosis. Annual Review of Medicine. 50: 291-302. PMID 10073279 DOI: 10.1146/Annurev.Med.50.1.291 |
0.346 |
|
| 1998 |
Qu ZX, Dayal A, Jensen MA, Arnason BG. All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Archives of Neurology. 55: 315-21. PMID 9520005 DOI: 10.1001/Archneur.55.3.315 |
0.336 |
|
| 1997 |
Arnason BG, Toscas A, Dayal A, Qu Z, Noronha A. Role of interferons in demyelinating diseases. Journal of Neural Transmission. Supplementum. 49: 117-23. PMID 9266421 DOI: 10.1007/978-3-7091-6844-8_13 |
0.313 |
|
| 1996 |
Arnason BG. Interferon beta in multiple sclerosis. Clinical Immunology and Immunopathology. 81: 1-11. PMID 8808634 DOI: 10.1006/Clin.1996.0149 |
0.379 |
|
| 1996 |
Lublin FD, Whitaker JN, Eidelman BH, Miller AE, Arnason BG, Burks JS. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology. 46: 12-8. PMID 8559358 DOI: 10.1212/Wnl.46.1.12 |
0.347 |
|
| 1995 |
Dayal AS, Jensen MA, Lledo A, Arnason BG. Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 45: 2173-7. PMID 8848188 DOI: 10.1212/Wnl.45.12.2173 |
0.333 |
|
| 1995 |
Arnason B. The role of cytokines in multiple sclerosis. Neurology. 45: S54-5. PMID 7783914 DOI: 10.1212/Wnl.45.6_Suppl_6.S54 |
0.377 |
|
| 1993 |
Martino G, DuPont BL, Wollmann RL, Bongioanni P, Anastasi J, Quintans J, Arnason BG, Grimaldi LM. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Annals of Neurology. 34: 48-56. PMID 8517679 DOI: 10.1002/Ana.410340110 |
0.311 |
|
| 1993 |
Lu CZ, Lu L, Hao ZS, Xia DG, Qain J, Arnason BG. Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. Journal of Neuroimmunology. 43: 145-9. PMID 8384634 DOI: 10.1016/0165-5728(93)90085-D |
0.301 |
|
| 1993 |
Lu CZ, Jensen MA, Arnason BG. Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. Journal of Neuroimmunology. 46: 123-8. PMID 7689582 DOI: 10.1016/0165-5728(93)90241-P |
0.391 |
|
| 1992 |
Arnason BG. Multiple sclerosis: additional thoughts. Journal of the Neurological Sciences. 107: 141-4. PMID 1564511 DOI: 10.1016/0022-510X(92)90281-O |
0.339 |
|
| 1992 |
Anlar B, Karaszewski JW, Reder AT, Arnason BG. Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis. Journal of Neuroimmunology. 36: 171-7. PMID 1346264 DOI: 10.1016/0165-5728(92)90048-P |
0.318 |
|
| 1991 |
Maimone D, Gregory S, Arnason BG, Reder AT. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. Journal of Neuroimmunology. 32: 67-74. PMID 2002092 DOI: 10.1016/0165-5728(91)90073-G |
0.317 |
|
| 1991 |
Reder AT, Arnason BG, Maimone D, Rohwer-Nutter D. The function of the CD2 protein is abnormal in multiple sclerosis. Journal of Autoimmunity. 4: 479-91. PMID 1680333 DOI: 10.1016/0896-8411(91)90160-E |
0.361 |
|
| 1991 |
Karaszewski JW, Reder AT, Anlar B, Kim WC, Arnason BG. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Annals of Neurology. 30: 42-7. PMID 1656847 DOI: 10.1002/Ana.410300109 |
0.344 |
|
| 1991 |
Arnason BG. Nervous - immune system interactions in MS Journal of Neuroimmunology. 35: 9. DOI: 10.1016/0165-5728(91)90846-Y |
0.328 |
|
| 1990 |
Chelmicka-Schorr E, Checinski ME, Arnason BG. Sympathetic nervous system and PC12 pheochromocytoma-derived factors suppress stimulation of lymphocytes. Brain, Behavior, and Immunity. 4: 23-9. PMID 2334814 DOI: 10.1016/0889-1591(90)90003-9 |
0.304 |
|
| 1990 |
Karaszewski JW, Reder AT, Maselli R, Brown M, Arnason BG. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Annals of Neurology. 27: 366-72. PMID 2162144 DOI: 10.1002/Ana.410270404 |
0.386 |
|
| 1988 |
Arnason BG, Noronha AB, Reder AT. Immunoregulation in rapidly progressive multiple sclerosis. Annals of the New York Academy of Sciences. 540: 4-12. PMID 2905124 DOI: 10.1111/J.1749-6632.1988.Tb27046.X |
0.342 |
|
| 1985 |
Grimaldi LM, Roos RP, Nalefski EA, Arnason BG. Oligoclonal IgA bands in multiple sclerosis and subacute sclerosing panencephalitis. Neurology. 35: 813-7. PMID 3889705 DOI: 10.1212/Wnl.35.6.813 |
0.34 |
|
| 1985 |
Corey AL, Richman DP, Shuman CA, Gomez CM, Arnason BG. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease. Neurology. 35: 1455-60. PMID 3875805 DOI: 10.1212/Wnl.35.10.1455 |
0.306 |
|
| 1985 |
Noronha A, Richman DP, Arnason BG. Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Annals of Neurology. 18: 722-5. PMID 3841270 DOI: 10.1002/Ana.410180617 |
0.343 |
|
| 1984 |
Arnason BG, Antel JP, Reder AT. Immunoregulation in multiple sclerosis. Annals of the New York Academy of Sciences. 436: 133-9. PMID 6241817 DOI: 10.1111/J.1749-6632.1984.Tb14785.X |
0.344 |
|
| 1984 |
Reder AT, Antel JP, Oger JJ, McFarland TA, Rosenkoetter M, Arnason BG. Low T8 antigen density on lymphocytes in active multiple sclerosis. Annals of Neurology. 16: 242-9. PMID 6236742 DOI: 10.1002/Ana.410160214 |
0.35 |
|
| 1984 |
Antel JP, Rosenkoetter M, Reder A, Oger JJ, Arnason BG. Multiple sclerosis: relation of in vitro IgG secretion to T suppressor cell number and function. Neurology. 34: 1155-60. PMID 6235461 DOI: 10.1212/Wnl.34.9.1155 |
0.373 |
|
| 1984 |
Antel JP, Peeples DM, Reder AT, Arnason BG. Analysis of T regulator cell surface markers and functional properties in multiple sclerosis. Journal of Neuroimmunology. 6: 93-103. PMID 6233299 DOI: 10.1016/0165-5728(84)90030-4 |
0.347 |
|
| 1984 |
Reder AT, Antel JP, Arnason BG. T regulator cell surface antigens in multiple sclerosis. Annals of the New York Academy of Sciences. 436: 247-53. PMID 6152383 DOI: 10.1111/J.1749-6632.1984.Tb14796.X |
0.323 |
|
| 1984 |
Miles K, Atweh S, Otten G, Arnason BG, Chelmicka-Schorr E. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice. International Journal of Immunopharmacology. 6: 171-7. PMID 6086537 DOI: 10.1016/0192-0561(84)90014-6 |
0.305 |
|
| 1983 |
Stefansson K, Marton L, Antel JP, Wollmann RL, Roos RP, Chejfec G, Arnason BG. Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathologica. 59: 255-61. PMID 6306978 DOI: 10.1007/Bf00691490 |
0.309 |
|
| 1983 |
Antel JP, Oger JJ, Wrabetz LG, Arnason BG, Hopper JE. Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humans. Mechanisms of Ageing and Development. 23: 11-9. PMID 6228697 DOI: 10.1016/0047-6374(83)90095-7 |
0.302 |
|
| 1983 |
Arnason BG. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurologic Clinics. 1: 765-82. PMID 6209540 DOI: 10.1016/S0733-8619(18)31147-2 |
0.327 |
|
| 1982 |
Mattson DH, Roos RP, Arnason BG. Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains. Journal of Neuroimmunology. 2: 261-76. PMID 7085864 DOI: 10.1016/0165-5728(82)90059-5 |
0.321 |
|
| 1982 |
Medof ME, Antel JP, Oger JJ, Prince GM, Arnason BG. Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid. Clinical and Experimental Immunology. 48: 25-36. PMID 7044631 |
0.467 |
|
| 1982 |
Wrabetz LG, Antel JP, Oger JJ, Arnason BG, Goust JM, Hopper JE. Age-related changes in in vitro immunoglobulin secretion: comparison of responses to T-dependent and T-independent polyclonal activators. Cellular Immunology. 74: 398-403. PMID 6891906 DOI: 10.1016/0008-8749(82)90040-5 |
0.303 |
|
| 1982 |
Mattson DH, Roos RP, Hopper JE, Arnason BG. Light chain composition of CSF oligoclonal IgG bands in multiple sclerosis and subacute sclerosing panencephalitis. Journal of Neuroimmunology. 3: 63-76. PMID 6808024 DOI: 10.1016/0165-5728(82)90018-2 |
0.325 |
|
| 1982 |
Oger JJ, Antel JP, Kuo HH, Arnason BG. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Annals of Neurology. 11: 177-81. PMID 6462102 DOI: 10.1002/Ana.410110211 |
0.409 |
|
| 1982 |
Antel J, Oger JJ, Jackevicius S, Kuo HH, Arnason BG. Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 79: 3330-4. PMID 6212930 DOI: 10.1073/Pnas.79.10.3330 |
0.322 |
|
| 1982 |
Arnason BG. Multiple sclerosis: current concepts and management. Hospital Practice (Office Ed.). 17: 81-9. PMID 6210614 DOI: 10.1080/21548331.1982.11698045 |
0.356 |
|
| 1982 |
Oger J, Szuchet S, Antel J, Arnason BG. A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature. 295: 66-8. PMID 6173754 DOI: 10.1038/295066A0 |
0.412 |
|
| 1981 |
Miles K, Quintáns J, Chelmicka-Schorr E, Arnason BG. The sympathetic nervous system modulates antibody response to thymus-independent antigens. Journal of Neuroimmunology. 1: 101-5. PMID 6799543 DOI: 10.1016/0165-5728(81)90012-6 |
0.315 |
|
| 1981 |
Antel JP, Medof ME, Oger JJ, Kuo HH, Arnason BG. Generation of suppressor cells by aggregated human globulin. Clinical and Experimental Immunology. 43: 351-6. PMID 6456096 |
0.459 |
|
| 1981 |
Iqbal A, Oger JJ, Arnason BG. Cell-mediated immunity in idiopathic polyneuritis. Annals of Neurology. 9: 65-9. PMID 6452855 DOI: 10.1002/Ana.410090711 |
0.325 |
|
| 1981 |
Mattson DH, Roos RP, Arnason BG. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Annals of Neurology. 9: 34-41. PMID 6163394 DOI: 10.1002/Ana.410090107 |
0.35 |
|
| 1980 |
Arnason BG, Waksman BH. Immunoregulation in multiple sclerosis. Annals of Neurology. 8: 237-40. PMID 7436367 DOI: 10.1002/Ana.410080302 |
0.549 |
|
| 1980 |
Mattson DH, Roos RP, Arnason BG. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature. 287: 335-7. PMID 7421992 DOI: 10.1038/287335A0 |
0.356 |
|
| 1980 |
Richman DP, Gomez CM, Berman PW, Burres SA, Fitch FW, Arnason BG. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature. 286: 738-9. PMID 7412861 DOI: 10.1038/286738A0 |
0.322 |
|
| 1980 |
Stefansson K, Antel JP, Oger J, Burns J, Noronha AB, Roos RP, Arnason BG, Gudmundsson G. Autosomal dominant cerebrovascular amyloidosis: properties of peripheral blood lymphocytes. Annals of Neurology. 7: 436-40. PMID 7396423 DOI: 10.1002/Ana.410070508 |
0.309 |
|
| 1980 |
Latts JR, Antel JP, Levinson DJ, Arnason BG, Medof ME. Histocompatibility antigens and gold toxicity: a preliminary report. Journal of Clinical Pharmacology. 20: 206-9. PMID 7381033 DOI: 10.1002/J.1552-4604.1980.Tb01698.X |
0.54 |
|
| 1980 |
Szuchet S, Stefansson K, Wollmann RL, Dawson G, Arnason BG. Maintenance of isolated oligodendrocytes in long-term culture. Brain Research. 200: 151-64. PMID 6251943 DOI: 10.1016/0006-8993(80)91101-4 |
0.301 |
|
| 1980 |
Noronha AB, Richman DP, Arnason BG. Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis. The New England Journal of Medicine. 303: 713-7. PMID 6157088 DOI: 10.1056/Nejm198009253031301 |
0.366 |
|
| 1979 |
Richman DP, Antel JP, Patrick JW, Arnason BG. Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology. 29: 291-6. PMID 571972 DOI: 10.1212/Wnl.29.3.291 |
0.314 |
|
| 1979 |
Antel JP, Arnason BG, Medof ME. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Annals of Neurology. 5: 338-42. PMID 312620 DOI: 10.1002/Ana.410050406 |
0.592 |
|
| 1979 |
Noronha AB, Roos RP, Antel JP, Arnason BG. Huntington's disease: abnormality of lymphocyte capping. Annals of Neurology. 6: 447-50. PMID 160212 DOI: 10.1002/Ana.410060512 |
0.3 |
|
| 1978 |
Antel JP, Weinrich M, Arnason BG. Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity. Neurology. 28: 999-1003. PMID 311447 DOI: 10.1212/Wnl.28.10.999 |
0.333 |
|
| 1978 |
Antel JP, Richman DP, Medof ME, Arnason BG. Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology. 28: 106-10. PMID 309564 DOI: 10.1212/Wnl.28.9_Part_2.106 |
0.577 |
|
| 1976 |
Wray SH, Cogan DG, Arnason BG. Experimental allergic encephalomyelitis. Passive transfer by the intraocular injection of sensitized cells. Archives of Neurology. 33: 183-5. PMID 1252161 DOI: 10.1001/Archneur.1976.00500030039008 |
0.32 |
|
| 1976 |
Lehrich JR, Arnason BG. Histocompatibility types and viral antibodies. Archives of Neurology. 33: 404-5. PMID 180933 DOI: 10.1001/Archneur.1976.00500060010003 |
0.341 |
|
| 1976 |
Richman DP, Patrick J, Arnason BG. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. The New England Journal of Medicine. 294: 694-8. PMID 129705 DOI: 10.1056/Nejm197603252941304 |
0.322 |
|
| 1975 |
Oger JF, Arnason BG, Wray SH, Kistler JP. A study of B and T cells in multiple sclerosis. Neurology. 25: 444-7. PMID 1079581 DOI: 10.1212/Wnl.25.5.444 |
0.337 |
|
| 1974 |
Arnason BG, Fuller TC, Lehrich JR, Wray SH. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. Journal of the Neurological Sciences. 22: 419-28. PMID 4847303 DOI: 10.1016/0022-510X(74)90078-1 |
0.333 |
|
| 1974 |
Lehrich JR, Oger J, Arnason BG. Neutralizing antibodies to poliovirus and mumps virus in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 23: 537-40. PMID 4374516 DOI: 10.1016/0022-510X(74)90025-2 |
0.305 |
|
| 1974 |
Lehrich JR, Arnason BG, Fuller TC, Wray SH. Parainfluenza, histocompatibility, and multiple sclerosis. Association of parainfluenza antibodies and histocompatibility types in MS and optic neuritis. Archives of Neurology. 30: 327-9. PMID 4361392 DOI: 10.1001/Archneur.1974.00490340055013 |
0.354 |
|
| 1973 |
Arnason BG. Editorial: Optic neuritis and multiple sclerosis. The New England Journal of Medicine. 289: 1140-1. PMID 4543182 DOI: 10.1056/Nejm197311222892109 |
0.354 |
|
| 1973 |
Hier DB, Arnason BG, Young M. Nerve growth factor: relationship to the cyclic AMP system of sensory ganglia. Science (New York, N.Y.). 182: 79-81. PMID 4354171 DOI: 10.1126/Science.182.4107.79 |
0.533 |
|
| 1972 |
Arnason BG, Chelmicka-Szorc E. Passive transfer of experimental allergic neuritis in Lewis rats by direct injection of sensitized lymphocytes into sciatic nerve. Acta Neuropathologica. 22: 1-6. PMID 5074155 DOI: 10.1007/Bf00687545 |
0.301 |
|
| 1972 |
Hier DB, Arnason BG, Young M. Studies on the mechanism of action of nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America. 69: 2268-72. PMID 4340752 DOI: 10.1073/Pnas.69.8.2268 |
0.54 |
|
| 1969 |
Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine. 48: 173-215. PMID 5769741 DOI: 10.1097/00005792-196905000-00001 |
0.352 |
|
| 1968 |
Arnason BG, Asbury AK, Aström KE, Adams RD. EAN as a model for idiopathic polyneuritis. Transactions of the American Neurological Association. 93: 133-6. PMID 4304007 |
0.315 |
|
| 1965 |
Appenzeller O, Arnason BG, Adams RD. Experimental autonomic neuropathy: an immunologically induced disorder of reflex vasomotor function. Journal of Neurology, Neurosurgery, and Psychiatry. 28: 510-5. PMID 5866605 |
0.346 |
|
| 1964 |
ARNASON BG, WAKSMAN BH. TUBERCULIN SENSITIVITY. IMMUNOLOGIC CONSIDERATIONS. Bibliotheca Tuberculosea. 19: 1-97. PMID 14271075 |
0.401 |
|
| 1962 |
JANKOVIC BD, WAKSMAN BH, ARNASON BG. Role of the thymus in immune ractions in rats. I. The immunologic response to bovine serum albumin (antibody formation, Arthus reactivity, and delayed hypersensitivity) in rats thymectomized or splenectomized at various times after birth. The Journal of Experimental Medicine. 116: 159-76. PMID 14451146 DOI: 10.1084/Jem.116.2.159 |
0.457 |
|
| 1962 |
WAKSMAN BH, ARNASON BG, JANKOVIC BD. Role of the thymus in immune reactions in rats. III. Changes in the lymphoid organs of thymectomized rats. The Journal of Experimental Medicine. 116: 187-206. PMID 14004487 DOI: 10.1084/Jem.116.2.187 |
0.462 |
|
| 1962 |
ARNASON BG, JANKOVIC BD, WAKSMAN BH. Effect of thymectomy on 'delayed' hypersensitive reactions. Nature. 194: 99-100. PMID 13862387 DOI: 10.1038/194099A0 |
0.466 |
|
| 1962 |
ARNASON BG, JANKOVIC BD, WAKSMAN BH, WENNERSTEN C. Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) hypersensitivity and the circulating small lymphocyte. The Journal of Experimental Medicine. 116: 177-86. PMID 13862386 DOI: 10.1084/Jem.116.2.177 |
0.451 |
|
| 1962 |
ARNASON BG, JANKOVIĆ BD, WAKSMAN BH. A Survey of the Thymus and Its Relation to Lymphocytes and Immune Reactions Blood. 20: 617-628. DOI: 10.1182/Blood.V20.5.617.617 |
0.452 |
|
| 1961 |
WAKSMAN BH, ARBOUYS S, ARNASON BG. The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. The Journal of Experimental Medicine. 114: 997-1022. PMID 14004486 DOI: 10.1084/Jem.114.6.997 |
0.448 |
|
| Show low-probability matches. |
